It was found that TGFβ1 levels in CAFs that were lower than the median were sufficient to promote cancer cell proliferation and inhibit cell apoptosis, while higher TGFβ1 levels inhibited antitumor immunity. The gene discussed is TGFB1; the disease is cancer.